Advertising
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »
TOP PICK
Seen to have levelled out and has seen some moves recently. A small speculative company. Market cap is $74M. Continues to make new highs. A pharmaceutical company with 2 advanced products in trial. Enhancing safety to treat chronic kidney disease. Has some usage for covid patiences.
biotechnology
RISKY BUY
Recently it's jumped from 10 to 17 cents/share. Reason: Covid attacks major organs (lungs, kidneys) and those with gout are particularly vulnerable; XRX has drugs to treat kidneys and uric acid (high levels lead to gout). XRX has two drugs going into phase-3 drug trials. He likes XRX a lot, but it's highly speculative though. XRX could out-license with one of three companies on a share-revenue basis.
biotechnology
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

XORTX Therapeutics (XRX-CN) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for XORTX Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

XORTX Therapeutics (XRX-CN) Frequently Asked Questions

What is XORTX Therapeutics stock symbol?

XORTX Therapeutics is a Canadian stock, trading under the symbol XRX-CN on the Canadian Securities Exchange (). It is usually referred to as or XRX-CN

Is XORTX Therapeutics a buy or a sell?

In the last year, 1 stock analyst published opinions about XRX-CN. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for XORTX Therapeutics .

Is XORTX Therapeutics a good investment or a top pick?

XORTX Therapeutics was recommended as a Top Pick by on . Read the latest stock experts ratings for XORTX Therapeutics .

Why is XORTX Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is XORTX Therapeutics worth watching?

1 stock analyst on Stockchase covered XORTX Therapeutics In the last year. It is a trending stock that is worth watching.

What is XORTX Therapeutics stock price?

On , XORTX Therapeutics (XRX-CN) stock closed at a price of $.